DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
ENOXOLONE
2
Small molecule
Investigational
Unknown
Unknown
Skin Ulcer
Unknown
ENOXOLONE
×
Maximum Phase:
2
First Approval:
None
UNII:
P540XA09DR
Molecule Type:
Small molecule
Molecular Formula:
C30H46O4
Molecular Weight:
470.69
AlogP:
6.41
PSA:
74.6
HBD:
2.0
HBA:
#RotB:
1.0
Source:
COSITECAN
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
COSITECAN
×
Maximum Phase:
2
First Approval:
None
UNII:
24R60NVC41
Molecule Type:
Small molecule
Molecular Formula:
C25H28N2O4Si
Molecular Weight:
448.6
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
DINALBUPHINE SEBACATE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
DINALBUPHINE SEBACATE
×
Maximum Phase:
2
First Approval:
None
UNII:
464OXX39Y6
Molecule Type:
Small molecule
Molecular Formula:
C52H68N2O10
Molecular Weight:
881.12
AlogP:
5.95
PSA:
158.46
HBD:
4.0
HBA:
#RotB:
15.0
Source:
PLAGUE VACCINE
2
Unknown
Investigational
Unknown
Unknown
Plague
Unknown
PLAGUE VACCINE
×
Maximum Phase:
2
First Approval:
None
UNII:
G10832YT0L
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ND0801
2
Small molecule
Investigational
Unknown
Unknown
Attention Deficit Disorder with Hyperactivity
Neuronal acetylcholine receptor protein alpha-7 subunit agonist
ND0801
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GLESATINIB
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Carcinoma, Non-Small-Cell Lung
Hepatocyte growth factor receptor inhibitor
GLESATINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
7Q29OXD98N
Molecule Type:
Small molecule
Molecular Formula:
C31H27F2N5O3S2
Molecular Weight:
619.72
AlogP:
6.22
PSA:
97.4
HBD:
3.0
HBA:
#RotB:
11.0
Source:
TALACTOFERRIN ALFA
2
Protein
Investigational
Unknown
Unknown
Infections; Sepsis; Carcinoma, Non-Small-Cell Lung
Unknown
TALACTOFERRIN ALFA
×
Maximum Phase:
2
First Approval:
None
UNII:
7A055A9QRR
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MILVETEROL
2
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive
Beta-2 adrenergic receptor agonist
MILVETEROL
×
Maximum Phase:
2
First Approval:
None
UNII:
LGY1VQ9622
Molecule Type:
Small molecule
Molecular Formula:
C25H29N3O4
Molecular Weight:
435.52
AlogP:
2.97
PSA:
113.85
HBD:
6.0
HBA:
#RotB:
12.0
Source:
EMICERFONT
2
Small molecule
Investigational
Unknown
Unknown
Irritable Bowel Syndrome; Phobia, Social
Corticotropin releasing factor receptor 1 antagonist
EMICERFONT
×
Maximum Phase:
2
First Approval:
None
UNII:
OJ8EG4264P
Molecule Type:
Small molecule
Molecular Formula:
C22H24N6O2
Molecular Weight:
404.47
AlogP:
3.12
PSA:
75.52
HBD:
1.0
HBA:
#RotB:
4.0
Source:
SODIUM NITRATE
2
Small molecule
Investigational
Unknown
Unknown
Cardiomyopathy, Hypertrophic; Ischemia; Angina, Stable; Asthma; Coronary Disease; Muscular Dystrophy, Duchenne
Unknown
SODIUM NITRATE
×
Maximum Phase:
2
First Approval:
None
UNII:
8M4L3H2ZVZ
Molecule Type:
Small molecule
Molecular Formula:
NNaO3
Molecular Weight:
84.99
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
GSK2269557
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GSK2269557
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ISUZINAXIB HYDROCHLORIDE
2
Small molecule
Investigational
Unknown
Unknown
Severe Acute Respiratory Syndrome
Unknown
ISUZINAXIB HYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C17H18ClN3O
Molecular Weight:
315.8
AlogP:
3.59
PSA:
50.94
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ZATOLMILAST
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease; Fragile X Syndrome
Phosphodiesterase 4D inhibitor
ZATOLMILAST
×
Maximum Phase:
2
First Approval:
None
UNII:
G786V328X6
Molecule Type:
Small molecule
Molecular Formula:
C21H15ClF3NO2
Molecular Weight:
405.8
AlogP:
5.64
PSA:
50.19
HBD:
1.0
HBA:
#RotB:
5.0
Source:
LANICEMINE
2
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder; Depressive Disorder, Major
Glutamate [NMDA] receptor blocker
LANICEMINE
×
Maximum Phase:
2
First Approval:
None
UNII:
9TMU325RK3
Molecule Type:
Small molecule
Molecular Formula:
C13H14N2
Molecular Weight:
198.27
AlogP:
2.32
PSA:
38.91
HBD:
1.0
HBA:
#RotB:
3.0
Source:
FOXY-5
2
Protein
Investigational
Unknown
Unknown
Colonic Neoplasms
Unknown
FOXY-5
×
Maximum Phase:
2
First Approval:
None
UNII:
CBZ9UL0ARB
Molecule Type:
Protein
Molecular Formula:
C26H42N6O12S2
Molecular Weight:
694.79
AlogP:
-2.69
PSA:
286.5
HBD:
10.0
HBA:
#RotB:
24.0
Source:
CDX-3379
2
Antibody
Investigational
Unknown
Unknown
Melanoma; Carcinoma, Squamous Cell
Receptor tyrosine-protein kinase erbB-3 inhibitor
CDX-3379
×
Maximum Phase:
2
First Approval:
None
UNII:
00X6I56YXR
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HT-0712
2
Small molecule
Investigational
Unknown
Unknown
Memory Disorders; Rhinitis, Allergic, Seasonal
Phosphodiesterase 4 inhibitor
HT-0712
×
Maximum Phase:
2
First Approval:
None
UNII:
2O43FXG9IG
Molecule Type:
Small molecule
Molecular Formula:
C25H31NO3
Molecular Weight:
393.53
AlogP:
4.79
PSA:
47.56
HBD:
1.0
HBA:
#RotB:
6.0
Source:
OBI-3424
2
Small molecule
Investigational
Unknown
Unknown
Leukemia, Biphenotypic, Acute
DNA cross-linking agent
OBI-3424
×
Maximum Phase:
2
First Approval:
None
UNII:
X6SH5T8H76
Molecule Type:
Small molecule
Molecular Formula:
C21H25N4O6P
Molecular Weight:
460.43
AlogP:
3.91
PSA:
105.0
HBD:
0.0
HBA:
#RotB:
9.0
Source:
RADAFAXINE
2
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder, Major
Unknown
RADAFAXINE
×
Maximum Phase:
2
First Approval:
None
UNII:
Q47741214K
Molecule Type:
Small molecule
Molecular Formula:
C13H18ClNO2
Molecular Weight:
255.74
AlogP:
2.27
PSA:
41.49
HBD:
2.0
HBA:
#RotB:
1.0
Source:
PIDOLIC ACID
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PIDOLIC ACID
×
Maximum Phase:
2
First Approval:
None
UNII:
SZB83O1W42
Molecule Type:
Small molecule
Molecular Formula:
C5H7NO3
Molecular Weight:
129.12
AlogP:
-0.65
PSA:
66.4
HBD:
2.0
HBA:
#RotB:
1.0
Source:
TENATUMOMAB
2
Antibody
Investigational
Unknown
Unknown
Unknown
Tenascin other
TENATUMOMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
7C201CLB71
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ONCOLYSIN S
2
Antibody
Investigational
Unknown
Unknown
Unknown
Neural cell adhesion molecule 1 binding agent
ONCOLYSIN S
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SRT-2104
2
Small molecule
Investigational
Unknown
Unknown
Atrophy; Colitis, Ulcerative; Muscular Atrophy; Pulmonary Disease, Chronic Obstructive; Sepsis; Diabetes Mellitus, Type 2; Psoriasis
NAD-dependent deacetylase sirtuin 1 activator
SRT-2104
×
Maximum Phase:
2
First Approval:
None
UNII:
4521NR0J09
Molecule Type:
Small molecule
Molecular Formula:
C26H24N6O2S2
Molecular Weight:
516.65
AlogP:
4.97
PSA:
84.65
HBD:
1.0
HBA:
#RotB:
6.0
Source:
BUDIODARONE
2
Small molecule
Investigational
Unknown
Unknown
Atrial Fibrillation
Unknown
BUDIODARONE
×
Maximum Phase:
2
First Approval:
None
UNII:
F5Y53150C8
Molecule Type:
Small molecule
Molecular Formula:
C27H31I2NO5
Molecular Weight:
703.35
AlogP:
6.48
PSA:
68.98
HBD:
0.0
HBA:
#RotB:
12.0
Source:
13-DEOXYDOXORUBICIN
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
13-DEOXYDOXORUBICIN
×
Maximum Phase:
2
First Approval:
None
UNII:
1S9VO1DQG5
Molecule Type:
Small molecule
Molecular Formula:
C27H31NO10
Molecular Weight:
529.54
AlogP:
0.82
PSA:
189.0
HBD:
6.0
HBA:
#RotB:
5.0
Source:
PEGVORHYALURONIDASE ALFA
2
Enzyme
Investigational
Unknown
Unknown
Cholangiocarcinoma; Esophageal Neoplasms; Neoplasms; Stomach Neoplasms; Adenocarcinoma; Carcinoma, Pancreatic Ductal; Pancreatic Neoplasms
Hyaluronic acid hydrolytic enzyme
PEGVORHYALURONIDASE ALFA
×
Maximum Phase:
2
First Approval:
None
UNII:
P01I4980ZS
Molecule Type:
Enzyme
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BLESELUMAB
2
Antibody
Investigational
Unknown
Unknown
Glomerulosclerosis, Focal Segmental; Psoriasis
Tumor necrosis factor receptor superfamily member 5 inhibitor
BLESELUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
AS3AZ5R46K
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OROTIC ACID
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
OROTIC ACID
×
Maximum Phase:
2
First Approval:
None
UNII:
61H4T033E5
Molecule Type:
Small molecule
Molecular Formula:
C5H4N2O4
Molecular Weight:
156.1
AlogP:
-1.24
PSA:
103.02
HBD:
3.0
HBA:
#RotB:
1.0
Source:
TERN-101
2
Unknown
Investigational
Unknown
Unknown
Non-alcoholic Fatty Liver Disease
Bile acid receptor FXR agonist
TERN-101
×
Maximum Phase:
2
First Approval:
None
UNII:
VVA2ZDV3LX
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HORSE CHESTNUT
2
Unknown
Investigational
Unknown
Unknown
Lymphedema
Unknown
HORSE CHESTNUT
×
Maximum Phase:
2
First Approval:
None
UNII:
3C18L6RJAZ
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ASTEGOLIMAB
2
Antibody
Investigational
Unknown
Unknown
Asthma; Dermatitis, Atopic; Pulmonary Disease, Chronic Obstructive; Severe Acute Respiratory Syndrome
Unknown
ASTEGOLIMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
27TW751DTH
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LCV
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
LCV
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DEXPRAMIPEXOLE DIHYDROCHLORIDE
2
Small molecule
Investigational
Unknown
Unknown
Amyotrophic Lateral Sclerosis
Unknown
DEXPRAMIPEXOLE DIHYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
795J01AE70
Molecule Type:
Small molecule
Molecular Formula:
C10H21Cl2N3OS
Molecular Weight:
302.27
AlogP:
1.58
PSA:
50.94
HBD:
2.0
HBA:
#RotB:
3.0
Source:
IMSIDOLIMAB
2
Antibody
Investigational
Unknown
Unknown
Acneiform Eruptions; Acne Vulgaris; Hidradenitis Suppurativa; Ichthyosis; Psoriasis
IL36 receptor antagonist
IMSIDOLIMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMS-813160
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Pancreatic Ductal; Hyperplasia; Diabetic Nephropathies; Neoplasms
C-C chemokine receptor type 2 antagonist
BMS-813160
×
Maximum Phase:
2
First Approval:
None
UNII:
83U7957287
Molecule Type:
Small molecule
Molecular Formula:
C25H40N8O2
Molecular Weight:
484.65
AlogP:
2.25
PSA:
116.55
HBD:
3.0
HBA:
#RotB:
5.0
Source:
1
2
…
172
173
174
175
176
177
178
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA